TAREQ SALOUS MD
Prescription History 1306367156
Internal Medicine - Hematology & Oncology in Indianapolis, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for TAREQ SALOUS MD, an active Hematology & Oncology specialist practicing in Indianapolis, IN. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 384 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisone, which accounts for 70 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Prednisone | 70 | $3.16▼ below IN avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 70 Medicare prescriptions for Prednisone, about 1.4 times the volume of the typical Indiana prescriber of this medication (48.5). Medicare paid an average of $3.16 per fill, versus $3.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 93 30-Day Fills standardized to 30-day supplies 2,663 Days of Medication total across all patients in 2024 | |||
| Abiraterone Acetate | 59 | $3,054.43 | ≈ Typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2024, this provider wrote 59 Medicare prescriptions for Abiraterone Acetate, about 1.2 times the volume of the typical Indiana prescriber of this medication (47.7). Medicare paid an average of $3,054.43 per fill, versus $1,809.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 59 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Olanzapine | 41 | $13.83▼ below IN avg | ≈ Typical |
About Olanzapine: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder). Show more ▾ It may also be used in combination with other medication to treat depression. Olanzapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section. A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. In 2024, this provider wrote 41 Medicare prescriptions for Olanzapine, about 77% of the volume of the typical Indiana prescriber of this medication (53.6). Medicare paid an average of $13.83 per fill, versus $32.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 47.4 30-Day Fills standardized to 30-day supplies 1,378 Days of Medication total across all patients in 2024 | |||
| OrgovyxRelugolix | 37 | $2,618.66▼ below IN avg | ▼ Less than typical |
About Orgovyx: Relugolix is used to treat prostate cancer in men. Show more ▾ It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread. Relugolix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells. In 2024, this provider wrote 37 Medicare prescriptions for Orgovyx, about 61% of the volume of the typical Indiana prescriber of this medication (60.8). Medicare paid an average of $2,618.66 per fill, versus $2,690.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,095 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 29 | $11.02▼ below IN avg | ≈ Typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 29 Medicare prescriptions for Ondansetron Odt, about the same volume as the typical Indiana prescriber of this medication (28.5). Medicare paid an average of $11.02 per fill, versus $18.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 29 30-Day Fills standardized to 30-day supplies 232 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 28 | $596.70▼ below IN avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 28 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical Indiana prescriber of this medication (102.9). Medicare paid an average of $596.70 per fill, versus $840.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 28 30-Day Fills standardized to 30-day supplies 827 Days of Medication total across all patients in 2024 | |||
| NubeqaDarolutamide | 25 | $14,617.77 | ▼ Less than typical |
About Nubeqa: Darolutamide is used to treat a certain type of prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. An androgen receptor inhibitor. In 2024, this provider wrote 25 Medicare prescriptions for Nubeqa, about 69% of the volume of the typical Indiana prescriber of this medication (36.2). Medicare paid an average of $14,617.77 per fill, versus $12,815.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| Mirtazapine | 17 | $27.02 | ▼ Less than typical |
About Mirtazapine: This medication is used to treat depression. Show more ▾ Mirtazapine works by helping to restore the balance of certain natural substances in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2024, this provider wrote 17 Medicare prescriptions for Mirtazapine, about a third of the volume of the typical Indiana prescriber of this medication (48.2). Medicare paid an average of $27.02 per fill, versus $19.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| Furosemide | 14 | $1.19▼ below IN avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2024, this provider wrote 14 Medicare prescriptions for Furosemide, about 14% of the volume of the typical Indiana prescriber of this medication (99). Medicare paid an average of $1.19 per fill, versus $4.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 14 30-Day Fills standardized to 30-day supplies 182 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 14 | $4.01▼ below IN avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 14 Medicare prescriptions for Oxycodone Hcl, about a quarter of the volume of the typical Indiana prescriber of this medication (53). Medicare paid an average of $4.01 per fill, versus $18.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 14 30-Day Fills standardized to 30-day supplies 133 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 13 | $5.63▼ below IN avg | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 13 Medicare prescriptions for Ondansetron Hcl, about a third of the volume of the typical Indiana prescriber of this medication (32.9). Medicare paid an average of $5.63 per fill, versus $52.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 101 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 13 | $7.62▼ below IN avg | ▼ Less than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 13 Medicare prescriptions for Prochlorperazine Maleate, about a third of the volume of the typical Indiana prescriber of this medication (37.7). Medicare paid an average of $7.62 per fill, versus $14.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 134 Days of Medication total across all patients in 2024 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $4.85▼ below IN avg | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 13 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about half the volume of the typical Indiana prescriber of this medication (27.3). Medicare paid an average of $4.85 per fill, versus $5.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 13 30-Day Fills standardized to 30-day supplies 176 Days of Medication total across all patients in 2024 | |||
| ErleadaApalutamide | 11 | $14,996.07 | ▼ Less than typical |
About Erleada: Apalutamide is used to treat men with prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. An androgen receptor antagonist. In 2024, this provider wrote 11 Medicare prescriptions for Erleada, about 19% of the volume of the typical Indiana prescriber of this medication (57.5). Medicare paid an average of $14,996.07 per fill, versus $14,204.54 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for TAREQ SALOUS MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Indianapolis, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
